We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
-0.84%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$2.48B
AUM Growth
+$119M
Cap. Flow
+$156M
Cap. Flow %
6.28%
Top 10 Hldgs %
35.06%
Holding
3,425
New
363
Increased
1,606
Reduced
626
Closed
191

Sector Composition

Rank Sector Weight
1 Technology 15.89%
2 Financials 8.07%
3 Healthcare 5.89%
4 Consumer Discretionary 5.37%
5 Communication Services 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KIN
3376
DELISTED
Kindred Biosciences, Inc.
KIN
-109
Closed -$1K
SYKE
3377
DELISTED
SYKES Enterprises Inc
SYKE
-838
Closed -$45K
MXIM
3378
DELISTED
Maxim Integrated Products
MXIM
-1,965
Closed -$207K
USCR
3379
DELISTED
U S Concrete, Inc.
USCR
-10
Closed -$1K
EVY
3380
DELISTED
Eaton Vance New York Municipal Income Trust
EVY
-2,001
Closed -$30K
WRI
3381
DELISTED
Weingarten Realty Investors
WRI
-210
Closed -$7K
NEBC
3382
DELISTED
Nebula Caravel Acquisition Corp. Class A Common Stock
NEBC
-100
Closed -$1K
NEBCU
3383
DELISTED
Nebula Caravel Acquisition Corp. Unit
NEBCU
-2,220
Closed -$23K
DGNR.U
3384
DELISTED
Dragoneer Growth Opportunities Corp. Units, each consisting of one Class A ordinary share, and one-f
DGNR.U
-1,836
Closed -$19K
SVACU
3385
DELISTED
Starboard Value Acquisition Corp. Unit
SVACU
-5,000
Closed -$52K
TLND
3386
DELISTED
Talend S.A. American Depositary Shares
TLND
-57
Closed -$4K
CAP.U
3387
DELISTED
Capitol Investment Corp. V Units, each consisting of one share of Class A common stock, and one-thir
CAP.U
-1,000
Closed -$10K
ALXN
3388
DELISTED
Alexion Pharmaceuticals
ALXN
-2,835
Closed -$521K
WORK
3389
DELISTED
Slack Technologies, Inc.
WORK
-38,633
Closed -$1.71M
AONE.U
3390
DELISTED
one Units, each consisting of one Class A ordinary share, and one-fourth of a Warrant to acquire one
AONE.U
-1,000
Closed -$11K
LMNX
3391
DELISTED
Luminex Corp
LMNX
-2,695
Closed -$99K
PRAH
3392
DELISTED
PRA Health Sciences, Inc.
PRAH
-928
Closed -$153K
CTST
3393
DELISTED
CannTrust Holdings Inc. Common Share
CTST
$0 ﹤0.01%
100
ADRE
3394
DELISTED
Invesco BLDRS Emerging Markets 50 ADR Index Fund
ADRE
-40
Closed -$2K
WPG
3395
DELISTED
Washington Prime Group Inc.
WPG
-104
Closed
GTT
3396
DELISTED
GTT Communications, Inc.
GTT
$0 ﹤0.01%
60
KNL
3397
DELISTED
Knoll, Inc.
KNL
-232
Closed -$6K
LUNA
3398
DELISTED
Luna Innovations Incorporated
LUNA
$0 ﹤0.01%
+18
New +$194
EBIX
3399
DELISTED
Ebix Inc
EBIX
$0 ﹤0.01%
+16
New +$469
REV
3400
DELISTED
Revlon, Inc.
REV
-69
Closed -$1K

Similar funds

Parallel Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Parallel Advisors held 3,425 positions worth $2.48B, up 5% from $2.36B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parallel Advisors deployed $156M of net new capital in Q3 2021, opening 363 new positions and adding to 1,606 existing holdings. Its largest new stake was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares US Medical Devices ETF, an estimated $15.9M trimmed.

  • Parallel Advisors's largest Q3 2021 buy was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.
  • Parallel Advisors added most to iShares Core MSCI EAFE ETF in Q3 2021, an estimated $24.8M increase.
  • Parallel Advisors's biggest Q3 2021 reduction was iShares US Medical Devices ETF, cutting an estimated $15.9M.
  • Parallel Advisors fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $1.71M.
  • Parallel Advisors's ten largest holdings make up 35% of its $2.48B portfolio in Q3 2021.
  • Parallel Advisors opened 363 new positions and closed 191 in Q3 2021.
  • Parallel Advisors's portfolio value rose 5% quarter-over-quarter to $2.48B.

Based on Parallel Advisors's 13F filing for Q3 2021, filed 22 Oct 2021.